CD8A and cancer: In addition, phosphoenolpyruvate carboxykinase 1 (PCK1) catalyzes the conversion of oxaloacetate (OAA) into PEP, and the overexpression of PCK1 enhances the cancer-killing functions of adoptive transferred CD4+ and CD8+T-cells [168].